Avalo Therapeutics Inc
(FRA:C6K0)
€
8.76
-0.04 (-0.45%)
Market Cap: 10.15 Mil
Enterprise Value: -73.04 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 46/100 - Avalo Therapeutics Inc Annual Shareholders Meeting TranscriptDec 20, 2023
- Avalo Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Avalo Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Avalo Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 13, 2023
- Avalo Therapeutics Inc Annual Shareholders Meeting TranscriptJun 14, 2022
- Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation TranscriptOct 19, 2021
- Cerecor Inc Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients - Corporate Call TranscriptJul 26, 2021
- Aytu BioScience Inc Acquires Prescription Product Portfolio from Cerecor Inc - M&A Call TranscriptOct 14, 2019
Avalo Therapeutics Inc at Jefferies Next Generation IBD Therapeutics Summit (Virtual) - Pre-recorded Presentation Transcript
Oct 19, 2021 / 12:00PM GMT
Release Date Price:
€5328
(-4.15%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)